Related Experiment Video
Updated: Aug 11, 2026
07:22
Laparoscopic Left Hemihepatectomy Combined with Caudate Lobe Resection
Published on: April 11, 2025
Liver resection for intrahepatic cholangiocarcinoma
Felice Giuliante1, Riccardo Gauzolino, Maria Vellone
1Department of Surgical Sciences, Unit of Hepatobiliary Surgery, Università Cattolica del Sacro Cuore, Largo A. Gemelli 8, 00168 Rome, Italy. fgiuliante@rm.unicatt.it
Tumori
|February 7, 2006
Summary
Radical surgical resection offers the best chance of cure for intrahepatic cholangiocarcinoma (IHCC). Achieving tumor-free margins (R0) in IHCC patients significantly improves survival rates, supporting a selective surgical approach.
Area of Science:
- Hepatobiliary Surgery
- Surgical Oncology
- Gastroenterology
Background:
- Intrahepatic cholangiocarcinoma (IHCC) is a rare but aggressive primary liver cancer, accounting for 10% of liver malignancies.
- Increasing incidence globally, yet limited data exists on surgical resection outcomes in Western populations.
- This study analyzes the institutional experience with surgical resection of IHCC.
Purpose of the Study:
- To evaluate the outcomes of surgical resection for intrahepatic cholangiocarcinoma (IHCC).
- To identify factors influencing survival after IHCC resection.
- To support evidence-based surgical management strategies for IHCC.
Main Methods:
- Retrospective analysis of 35 IHCC patients treated between 1987 and 2003.
- Fifteen patients underwent hepatic resection, including major and minor resections.
- Tumor classification based on the Liver Cancer Study Group of Japan criteria; assessment of resection margins (R0/R1).
Main Results:
- Postoperative mortality was 6.6% with a morbidity rate of 21.4%.
- Overall 1- and 3-year survival rates were 86% and 49%, respectively.
- Curative (R0) resections and early-stage (TNM I-II) tumors demonstrated significantly longer survival.
Conclusions:
- Surgical resection, when achievable with tumor-free margins (R0), is crucial for IHCC treatment.
- Accurate patient selection and aiming for radical resection are key to improving outcomes.
- Radical surgery remains the only curative option for intrahepatic cholangiocarcinoma.
